Natco Lenalid 25mg |Lenalidomide tablet-uses,side effects,dose,price in India

LENALID 25MG


lenalid 25mg tablet

MYELODYSPLASTIC SYNDROME


DESCRIPTION

Lenalid 25mg contains Lenalidomide as an active substance which belongs to thalidomide analogue. Lenalid 25mg contains some pharmacological activities like immuno modulatory, anti-neoplastic, & anti-angiogenesis. Lenalid 25mg is available in various strengths like 5mg, 10mg, 15mg & 25mg.

Lenalid 25mg is a prescription medicine; used under the supervision of medical oncologist. Lenalid 25mg is used by combining with dexamethasone.

INDICATION

The most common indications of Lenalid 25mg tablet are; Multiple myeloma: Lenalid 25mg should be used in combination with dexamethasone. Myelodysplastic syndrome: Lenalid 25mg is used to treat this condition Mantle cell lymphoma: Lenalid 25mg is used for this condition, if patients are not responding to the Bortezomib treatment.

MECHANISM

Lenalid 25mg tablet includes in the restraint of tumor rot factor alpha arrangement, which support the T-cells and causes lessening serum levels of cytokines vascular endothelial development factor and fundamental fibroblast development factor. Lenalid 25mg is additionally engaged with the preclusion of angiogenesis. Lenalidomide is additionally empowered G1 cell cycle capture and apoptosis of ruinous cells.

lenalid 25mg tablet
LENALID 25MG


Brand : Lenalid
Ingredients : Lenalidomide
Strength : 25mg
Manufactured : Natco
Package : 30 Tablets

DOSAGE MANAGEMENT

The usual prescribed dose of Lenalid in myelodysplastic syndromes is 10mg should be given as once a day. For renal damaged patients; In Patients with CrCl >60ml/min should not require dosage adjustment of Lenalid . In Patients with CrCl 30 to 60ml/min, 25mg of Lenalid should be given orally as once a day. In Patient with CrCl < 30ml/min, 2.25mg of Lenalid should be administered orally as a once a day. Dosage variation;THROMBOCYTOPENIA

Drops to <50000/mcL, therapy should be interrupted. Back to > or equal to 50000/mcL, continue the Lenalid of 25mg/day.NEUTROPENIA

Drops to <500/mcL, therapy should be postponed. Back to > or equal to 500/mcL, treatment should be continue to 25mg/day.MULTIPLE MYELOMA

In this condition, Lenalid is concomitant with dexamethasone. The usual dose of Lenalid is 225mg should be administered as once daily on day 1 to 21. The dose of dexamethasone; 40mg of dexamethasone should be followed on day 1 to 4, 9 to 12 & 17 to 20 of each 28 day cycles. Patient with >75 years, 20mg of dexamethasone should be recommended on day 1, 8, 15, & 22.MANTLE CELL LYMPHOMA

The advised dose of Lenalid for this condition is 225mg should be administered orally as once daily. For renal damaged patients; Patient with CrCl 30 to 60ml/min, 10mg of Lenalid should be administered as once daily. Patient with CrCl < 30ml/min, 125mg of Lenalid should be used for q48hr. Pediatrics; The potency & effectiveness of Lenalidomide has not been evaluated in pediatric patients with age of <18 years.

FOR MORE INFO

MOBILE NO : +91-9940472902

EMAIL : millionhealthpharmaceuticals@gmail.com

WEBSITE URL : https://millionpharma.com/lenalid-25mg.php

Comments

Post a Comment

Popular posts from this blog

Pomalid 1mg Capsule Uses, Price, Side Effects, Composition, Substitutes,MRP, Cost India.

Image
                                         POMALID 1MG pomalid 1mg,pomalid 1mg capsules,pomalid 1mg price in india,pomalid 1mg side effects,pomalid 1mg uses                                                      DESCRIPTION Drug profile Pomalid 1mg Contain Pomalidomide, Pomalid 1Mg capsule used along with dexamethasone to treat a type of cancer known as multiple myeloma. Mode Of Action Pomalid 1Mg Capsules Is In A Class of medication called immunomodulatory agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells in the bone marrow. Dosage The Recommended Dose Of Pomalidomide is 2Mg once Daily orally on Daily, until disease progression. Pomalidomide should be given in the combination of Dexamethasone. Pomalid 1mg may be taken with water, inform patient not to break ,chew,or open the capsule. Pomalid 1mg price in india may be talken with or without food. How To Take Pomalidomide Pomalid 1Mg Available In three Strength
Read more

Pomahope 4mg capsules | Pomalidomide |Millionpharma

Image
POMAHOPE 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 4mg and it belongs to anti-neoplastic drugs Pomahope 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 4mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 4mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 4mg Capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi
Read more

Bevacizumab Bevatas 100mg - Anticancer drugs | Intas | MHP

Image
BEVATAS GLIOBLASTOMA MULTIFORME DESCRIPTION Bevacizumab is a drug sold under the name of Bevatas and which is categorized as monoclonal anti-body & anti-angiogenesis  When Bevatas 100mg concomitant use with human monoclonal antibody IgG1, that circumstance and prohibits the biological action of human vascular endothelial growth factor (VEGF) USAGE Bevatas 100mg is indicated for the treatment of some of the conditions like Metastatic colon or rectal cancer Non-squamous, non-small cell lung cancer Glioblastoma Metastatic renal cell cancer Metastatic cervical cancer Epithelial ovarian, fallopian tube or peritoneal cancer MECHANISM OF ACTION Bevatas 100mg Injection comprises an active compound like Bevacizumab which binds to VEGF and avoid the communication of VEGF to its receptors like Flt-1 & KDR) present on the surface of the cells This interaction prevents endothelial cell multiplication and new blood vessel production occurs Hence in counts cessation
Read more